/XAGE
XAGE Stock - Longevity Health Holdings Inc.
Healthcare|BiotechnologyOTC
$0.43-5.29%
$0.02 (-5.29%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.47
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for XAGE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.43 – $0.43
TARGET (TP)$0.49
STOP LOSS$0.40
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.33
52W High$36.00
52W Low$0.37
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $50,318 | N/A | N/A | N/A |
| Gross Profit | $43,961 | $-124,788 | $-242,556 | N/A |
| Gross Margin | 87.4% | N/A | N/A | N/A |
| Operating Income | $-4,998,498 | $-5,217,280 | $-5,507,641 | $-467,431 |
| Net Income | $-10,368,261 | $-15,445,087 | $-9,051,334 | $-6,478,923 |
| Net Margin | -20605.5% | N/A | N/A | N/A |
| EPS | $-0.50 | $-0.74 | $-0.50 | $-0.01 |
Company Overview
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
XAGEBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.83
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-0.83 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-1.56 | — | — |
Q2 2025 | May 21, 2025 | — | $-4.80 | — | — |
Q2 2025 | May 15, 2025 | — | $-1.52 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.14 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.16 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.16 | — | — |
Q1 2024 | Mar 26, 2024 | — | $0.29 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.62 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.62 | — | — |
Q1 2023 | Mar 30, 2023 | — | $0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.16 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.32 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 20, 2022 | — | $-0.03 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 13, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about XAGE
What is XAGE's current stock price?
Longevity Health Holdings Inc. (XAGE) is currently trading at $0.43 per share. The stock has moved -5.29% today.
What is the analyst price target for XAGE?
No analyst price targets are currently available for this stock.
What sector is Longevity Health Holdings Inc. in?
Longevity Health Holdings Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is XAGE's market cap?
Longevity Health Holdings Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does XAGE pay dividends?
No, Longevity Health Holdings Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADTX
Aditxt, Inc.
$1.17
Mkt Cap: $0.0B
CCM
Concord Medical Services Holdings Limited
$4.15
Mkt Cap: $0.0B
CELU
Celularity Inc.
$1.45
Mkt Cap: $0.0B
HEPA
Hepion Pharmaceuticals, Inc.
$0.07
Mkt Cap: $0.0B
IVF
INVO Fertility, Inc.
$0.33
Mkt Cap: $0.0B
LIXT
Lixte Biotechnology Holdings, Inc.
$4.32
Mkt Cap: $0.0B
SCNI
Scinai Immunotherapeutics Ltd.
$0.79
Mkt Cap: $0.0B
SISI
Shineco, Inc.
$0.38
Mkt Cap: $0.0B
SYRA
Syra Health Corp. Class A Common Stock
$0.11
Mkt Cap: $0.0B
ZVSA
ZyVersa Therapeutics, Inc.
$0.14
Mkt Cap: $0.0B
Explore stocks similar to XAGE for comparison